Switch to:
Also traded in: Germany, UK

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash-to-Debt 0.07
PAH's Cash-to-Debt is ranked lower than
93% of the 1137 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.83 vs. PAH: 0.07 )
Ranked among companies with meaningful Cash-to-Debt only.
PAH' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.06  Med: 0.14 Max: 0.86
Current: 0.07
0.06
0.86
Equity-to-Asset 0.28
PAH's Equity-to-Asset is ranked lower than
89% of the 1096 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.56 vs. PAH: 0.28 )
Ranked among companies with meaningful Equity-to-Asset only.
PAH' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.21  Med: 0.27 Max: 0.55
Current: 0.28
0.21
0.55
Debt-to-Equity 1.88
PAH's Debt-to-Equity is ranked lower than
93% of the 867 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.41 vs. PAH: 1.88 )
Ranked among companies with meaningful Debt-to-Equity only.
PAH' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.49  Med: 1.83 Max: 2.64
Current: 1.88
0.49
2.64
Debt-to-EBITDA 8.31
PAH's Debt-to-EBITDA is ranked lower than
92% of the 910 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 2.09 vs. PAH: 8.31 )
Ranked among companies with meaningful Debt-to-EBITDA only.
PAH' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 4.58  Med: 11.61 Max: 16.21
Current: 8.31
4.58
16.21
Interest Coverage 0.87
PAH's Interest Coverage is ranked lower than
96% of the 1020 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 32.34 vs. PAH: 0.87 )
Ranked among companies with meaningful Interest Coverage only.
PAH' s Interest Coverage Range Over the Past 10 Years
Min: 0.25  Med: 0.67 Max: 2.34
Current: 0.87
0.25
2.34
Piotroski F-Score: 6
Altman Z-Score: 0.56
Beneish M-Score: -2.67
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 5/10

vs
industry
vs
history
Operating Margin % 8.19
PAH's Operating Margin % is ranked higher than
52% of the 1114 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 7.82 vs. PAH: 8.19 )
Ranked among companies with meaningful Operating Margin % only.
PAH' s Operating Margin % Range Over the Past 10 Years
Min: 1.13  Med: 7.07 Max: 15.74
Current: 8.19
1.13
15.74
Net Margin % -4.28
PAH's Net Margin % is ranked lower than
85% of the 1114 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 5.78 vs. PAH: -4.28 )
Ranked among companies with meaningful Net Margin % only.
PAH' s Net Margin % Range Over the Past 10 Years
Min: -12.14  Med: -2.06 Max: 6.29
Current: -4.28
-12.14
6.29
ROE % -5.49
PAH's ROE % is ranked lower than
84% of the 1101 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 9.33 vs. PAH: -5.49 )
Ranked among companies with meaningful ROE % only.
PAH' s ROE % Range Over the Past 10 Years
Min: -15.04  Med: -7.61 Max: 1.03
Current: -5.49
-15.04
1.03
ROA % -1.50
PAH's ROA % is ranked lower than
83% of the 1143 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 4.81 vs. PAH: -1.50 )
Ranked among companies with meaningful ROA % only.
PAH' s ROA % Range Over the Past 10 Years
Min: -4.19  Med: -0.81 Max: 7.46
Current: -1.5
-4.19
7.46
ROC (Joel Greenblatt) % 24.76
PAH's ROC (Joel Greenblatt) % is ranked higher than
72% of the 1138 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 14.24 vs. PAH: 24.76 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
PAH' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 1.34  Med: 13.38 Max: 99.98
Current: 24.76
1.34
99.98
» PAH's 30-Y Financials

Financials (Next Earnings Date: 2018-02-28)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q4 2016

PAH Guru Trades in Q4 2016

Paul Singer 10,951,281 sh (New)
Paul Tudor Jones 345,342 sh (+280.28%)
Larry Robbins 13,847,112 sh (+34.51%)
Mario Gabelli 60,000 sh (+27.66%)
Jim Simons 215,200 sh (+15.02%)
John Griffin 12,785,000 sh (unchged)
David Dreman 1,352 sh (unchged)
Bill Ackman 40,451,506 sh (-5.35%)
Murray Stahl 932,507 sh (-73.22%)
» More
Q1 2017

PAH Guru Trades in Q1 2017

Joel Greenblatt 18,388 sh (New)
George Soros 247,076 sh (New)
Chuck Royce 100,000 sh (New)
Paul Tudor Jones 696,230 sh (+101.61%)
Jim Simons 351,900 sh (+63.52%)
Mario Gabelli 65,000 sh (+8.33%)
John Griffin 12,785,000 sh (unchged)
Paul Singer 10,951,281 sh (unchged)
Bill Ackman 40,451,506 sh (unchged)
David Dreman Sold Out
Murray Stahl 888,918 sh (-4.67%)
Larry Robbins 11,203,633 sh (-19.09%)
» More
Q2 2017

PAH Guru Trades in Q2 2017

Joel Greenblatt 111,082 sh (+504.10%)
Jim Simons 783,172 sh (+122.56%)
Paul Tudor Jones 852,097 sh (+22.39%)
Larry Robbins 13,203,633 sh (+17.85%)
Mario Gabelli 65,000 sh (unchged)
Bill Ackman 40,451,506 sh (unchged)
Paul Singer 10,951,281 sh (unchged)
Caxton Associates 100,000 sh (unchged)
George Soros Sold Out
Chuck Royce 96,000 sh (-4.00%)
John Griffin 10,711,700 sh (-16.22%)
Murray Stahl 618,756 sh (-30.39%)
» More
Q3 2017

PAH Guru Trades in Q3 2017

Larry Robbins 14,328,633 sh (+8.52%)
Bill Ackman 40,451,506 sh (unchged)
Mario Gabelli 65,000 sh (unchged)
Paul Singer 10,951,281 sh (unchged)
Chuck Royce 92,200 sh (-3.96%)
Murray Stahl 587,157 sh (-5.11%)
Jim Simons 692,699 sh (-11.55%)
John Griffin 9,335,000 sh (-12.85%)
Paul Tudor Jones 661,925 sh (-22.32%)
Joel Greenblatt 15,530 sh (-86.02%)
» More
» Details

Insider Trades

Latest Guru Trades with PAH

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2017-09-30 Reduce -86.02%0.02%$10.92 - $14.58 $ 9.99-19%15,530
Joel Greenblatt 2017-06-30 Add 504.10%0.02%$12.11 - $14.32 $ 9.99-24%111,082
George Soros 2017-06-30 Sold Out 0.09%$12.11 - $14.32 $ 9.99-24%0
George Soros 2017-03-31 New Buy0.09%$9.83 - $13.47 $ 9.99-19%247,076
Mario Gabelli 2017-03-31 Add 8.33%$9.83 - $13.47 $ 9.99-19%65,000
Joel Greenblatt 2017-03-31 New Buy$9.83 - $13.47 $ 9.99-19%18,388
David Dreman 2017-03-31 Sold Out 0.01%$9.83 - $13.47 $ 9.99-19%0
Bill Ackman 2016-12-31 Reduce -5.35%0.34%$7.17 - $10.4 $ 9.9917%40,451,506
Mario Gabelli 2016-12-31 Add 27.66%$7.17 - $10.4 $ 9.9917%60,000
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Chemicals » Specialty Chemicals    NAICS: 325998    SIC: 2899
Compare:XKRX:011790, TSE:4471, SZSE:300221, SZSE:300037, NSE:AKZOINDIA, BOM:524208, TSE:4633, SHSE:603010, TSE:4626, NSE:SOLARINDS, SHSE:603737, SZSE:300054, SZSE:300225, NYSE:OEC, TSX:CHE.UN, TSE:4628, SZSE:300174, TPE:1314, SZSE:300409, SHSE:603826 » details
Traded in other countries:PLQ.Germany, PAH.UK,
Headquarter Location:USA
Platform Specialty Products Corp is a producer of high technology specialty chemical products and provider of post-sale technical services.

Platform Specialty Products Corp is a producer of high technology specialty chemical products and provider of post-sale technical services.

Guru Investment Theses on Platform Specialty Products Corp

Bill Ackman Comments on Platform - Nov 16, 2017

Platform (NYSE:PAH)’s earnings continued to grow this quarter as growth in the Performance Solutions business offset a decline in the Ag Solutions business. Platform’s organic revenue declined 1%, as Performance Solutions grew 4% and Ag Solutions declined 5%. The growth in the Performance Solutions segment continued to be driven by the positive results of the electronics business it recently acquired from Alent and strength in its industrial business. The decline in Ag Solutions resulted primarily from the ongoing drought in Brazil, which has caused buyers to delay their typical purchases in advance of the planting season. If the drought abates within the next few months, management believes it is likely it will recover these sales in future quarters.

Platform’s organic EBITDA increased 1%. Performance Solutions organic EBITDA grew 4% due to revenue growth and ongoing cost synergies from the acquisition of Alent, which was somewhat offset by a higher mix of sales from lower margin products. Ag Solutions organic EBITDA declined 3%, as the portion of sales from higher-margin products increased and the company continued to reduce structural costs.

Platform’s overall EBITDA grew 3% due to a 2% tailwind from foreign exchange. As a result of interest savings from the company’s recent debt refinancing and its leveraged capital structure, EPS grew roughly 18%.

At the end of August, Platform announced that it intends to separate its Ag and Performance Solutions businesses into two publicly traded companies in order to increase long-term value. Management expects the separation to occur by the middle of next year, and is likely be effectuated by an IPO of the Ag business.


From Bill Ackman (Trades, Portfolio)'s third quarter 2017 shareholder letter.

Check out Bill Ackman latest stock trades

Bill Ackman Comments on Platform Specialty Products Corp - Aug 18, 2017

Platform (NYSE:PAH) reported strong earnings this quarter due to continued organic revenue growth and positive results from its ongoing cost savings initiatives. Platform’s organic revenue increased 2%, as Performance Solutions grew 6% and Ag Solutions declined 2%. The growth in the Performance Solutions segment was due primarily to the positive results of the electronics business it recently acquired from Alent and strength in its industrial business. The modest decline in Ag Solutions resulted from poor weather conditions in Eastern Europe and the restructuring of its business in Africa. Ag Solutions reported positive growth in all of its key regions outside of Eastern Europe and Africa.

Platform’s organic EBITDA increased 8% due to strong results in both segments. Performance Solutions organic EBITDA grew 7% due to revenue growth and ongoing cost synergies from the acquisition of Alent, which was somewhat offset by a higher mix of sales from lower margin products. Ag Solutions organic EBITDA grew 9% in spite of the decline in revenue due to increased sales of higher-margin products and continued cost reductions in the business.

Platform’s overall EBITDA grew 6% due to a 2% headwind from the strengthening U.S. dollar. As a result of interest savings from the company’s recent debt refinancing and its leveraged capital structure, EPS grew roughly 25%.

From Bill Ackman (Trades, Portfolio)'s second quarter 2017 shareholder letter.

Check out Bill Ackman latest stock trades

Bill Ackman Comments on Platform Specialty Products Corp - May 12, 2017

Platform (NYSE:PAH) reported strong earnings growth for the first quarter. The company generated organic EBITDA growth of 18%, due to revenue growth in both of its businesses and improved cost efficiencies, both at the segment and corporate level. Organic revenue growth was 3%, due to 5% organic growth in Performance Solutions and 2% organic growth in Agricultural Solutions. Performance Solutions showed particular strength this quarter in its industrial and Asian electronics segments, as its end markets have improved and the integration of Alent has helped Platform gain market share. Agricultural Solutions growth was driven by strength in Latin America, but offset somewhat by weakness in Europe due to poor weather.

Performance Solutions organic EBITDA grew 27%, due primarily to further cost synergies from the Alent acquisition and continued cost efficiencies. Agriculture Solutions organic EBITDA grew 8% due primarily to a larger sales mix of higher margin products and cost reductions related to its recently announced $100 million cost savings initiative.

In April, Platform refinanced an additional $1.9 billion of debt reducing its interest costs by 1%. Since last October, the company has refinanced more than $5 billion of debt, lowering the associated interest rate by 1% and extending the maturity on a substantial portion of its debt by three years.



From Bill Ackman (Trades, Portfolio)'s first quarter 2017 shareholder letter.


Check out Bill Ackman latest stock trades

Bill Ackman Comments on Platform Specialty Products Corp - May 08, 2017

2016 was a year of stabilization and progress for Platform (NYSE:PAH). The company solidified its core leadership team, as key new hires, including CEO Rakesh Sachdev and Ag President Diego Casanello started in early 2016. Platform returned to positive organic growth despite continued softness in its end markets, delivered on synergy commitments from its recent acquisitions, and improved its capital structure through a $400 million equity issuance and a $3 billion debt refinancing that lowered the interest rate and extended the maturity of the company’s debt.

PAH’s underlying EBITDA (adjusted for currency effects) grew 6% in 2016, due to improved results in both the Performance Solutions and Agricultural Solutions businesses. Underlying EBITDA in Performance Solutions division grew 9% due to strong performance in the Asian electronics and industrial markets and cost synergies from the recent acquisition of Alent, while Agricultural Solutions grew 3% due to strength in the European and Latin America regions and continued cost synergies. Overall, PAH’s EBITDA grew 4% in 2016 reflecting a modest headwind from foreign exchange.

Despite positive progress, Platform’s share price declined 23.5% in 2016. However, in the first two months of 2017, Platform’s share price appreciated 34%, more than offsetting the decline in 2016. Platform continues to trade at a discount to its publicly traded segment peers and private-market transaction values.

From 2016 annual letter to shareholders of Pershing Square by Bill Ackman (Trades, Portfolio).

Check out Bill Ackman latest stock trades

Bill Ackman Comments on Platform Specialty Products - Mar 30, 2017



2016 was a year of stabilization and progress for Platform (NYSE:PAH). The company solidified its core leadership team, as key new hires, including CEO Rakesh Sachdev and Ag President Diego Casanello started in early 2016. Platform returned to positive organic growth despite continued softness in its end markets, delivered on synergy commitments from its recent acquisitions, and improved its capital structure through a $400 million equity issuance and a $3 billion debt refinancing that lowered the interest rate and extended the maturity of the company’s debt.

PAH’s underlying EBITDA (adjusted for currency effects) grew 6% in 2016, due to improved results in both the Performance Solutions and Agricultural Solutions businesses. Underlying EBITDA in Performance Solutions division grew 9% due to strong performance in the Asian electronics and industrial markets and cost synergies from the recent acquisition of Alent, while Agricultural Solutions grew 3% due to strength in the European and Latin America regions and continued cost synergies. Overall, PAH’s EBITDA grew 4% in 2016 reflecting a modest headwind from foreign exchange.

Despite positive progress, Platform’s share price declined 23.5% in 2016. However, in the first two months of 2017, Platform’s share price appreciated 34%, more than offsetting the decline in 2016. Platform continues to trade at a discount to its publicly traded segment peers and private-market transaction values.



From Bill Ackman (Trades, Portfolio)'s Pershing Square 2016 annual report.


Check out Bill Ackman latest stock trades

Bill Ackman Comments on Platform Specialty Products Corp - Dec 09, 2016

In September, Platform (NYSE:PAH) hosted an investor day where it provided a detailed explanation of the secular growth drivers and unique competitive positioning of each of its Performance and Agricultural Solutions businesses, along with long-term guidance of 4% annual organic revenue growth and high-single digit annual EBITDA growth.

The company also announced that it had reached a revised agreement with Permira to settle its $600 million preferred stock liability related to the Arysta acquisition. Under the revised agreement, Platform has the option to pay Permira $450 million in cash and 5.5 million shares, which equates to $500 million at the current market prices and represents a savings of $100 million relative to the original agreement. To finance the cash portion of the agreement, the company raised $400 million of equity and, as a result, was able to refinance $2 billion of its debt, reducing the rate on this debt by 50 basis points and extending the maturities by three years to 2023.

At the beginning of November, Platform reported strong third quarter earnings. The company delivered 3% organic revenue growth, comprised of 4% growth in Agricultural Solutions and 2% in Performance Solutions. The results are particularly impressive given the cyclical weakness in the company’s end markets. EBITDA grew 14%, due to 5% growth before synergies and corporate costs, 6% impact from net synergies, and 3% from FX.

From Bill Ackman (Trades, Portfolio)'s Pershing Square third-quarter shareholder letter.

Check out Bill Ackman latest stock trades

Bill Ackman Comments on Platform Specialty Products - Aug 29, 2016

Platform (NYSE:PAH)'s earnings declined in the second quarter as positive results in Performance Solutions, increased cost synergies, and strong growth in the International Ag Solutions were offset by a significant decline in the North American Ag Solutions business and increased corporate costs.

Platform's organic revenue increased 1% as Ag Solutions grew 5% and Performance Solutions revenue declined 2%. Ag Solutions achieved double-digit growth outside of North America (more than 80% of segment revenue), which was offset by a more than 40% decline in North America. The decline in North America resulted from the continued reduction in distributor channel inventories, decreased demand for pesticides due to lower pest pressures, and lower market share. The company stated that it has made changes to its sales force and product development initiatives and expects these efforts to improve business results over time. Performance Solutions' organic revenue declined primarily due to weakness in the electronics market in Asia, which the company noted should return to growth in the second half of the year.

Platform's organic EBITDA was down nearly 6%, as the growth in Performance Solutions and cost synergies were more than offset by the decline in Ag Solutions and higher corporate costs. In Performance Solutions, organic EBITDA increased 4%, as an improved sales mix of higher-margin products and cost synergies more than offset an increase in corporate expenses. In Ag Solutions, organic EBITDA declined 15%, as the higher sales mix of lower-margin products and the declines in the relatively higher-margin North American business more than offset increased cost synergies. Reported EBITDA declined 10% due to the negative headwinds from FX. As a result, EPS declined 36% due to the negative impact of financial leverage.

While Platform delivered mixed performance for the quarter, we are starting to see business progress under Platform's new CEO Rakesh Sachdev. We think highly of Rakesh and believe he possesses the necessary leadership qualities and experience to improve the performance of Platform.

From Bill Ackman (Trades, Portfolio)'s mid-year 2016 letter.

Check out Bill Ackman latest stock trades

Bill Ackman Comments on Platform Specialty Products Corp - May 11, 2016

Platform (NYSE:PAH) reported modestly improved underlying earnings due to strong cost synergies from its recent acquisitions, which were offset by weakness in several key end markets and an increase in corporate costs. Reported earnings were lower than the prior year due to significant headwinds from FX. Still, earnings beat expectations leading to a substantial increase in PAH’s stock price.

Platform’s organic revenue declined 1% as Ag Solutions was flat and Performance Solutions was down 2%. Ag Solutions achieved solid growth in Europe and Latin America, which was offset by market weakness in North America. Performance Solutions’ organic revenue declined primarily due to weakness in the electronics market in Asia. Although several of the company’s end markets have softened recently, Platform’s underlying results continue to outpace its competitors. Platform’s organic EBITDA was up slightly, as the benefit of cost synergies more than offset the increase in corporate costs. In Ag Solutions, organic EBITDA increased 3%, as higher cost synergies more than offset the increase in corporate expenses. In Performance Solutions, organic EBITDA declined 2%, as cost synergies were more than offset by the increase in corporate expenses. Reported EBITDA declined 6% due to the negative headwinds from FX. As a result, EPS declined nearly 30% due to the negative impact from financial leverage.

Based on its first quarter results, Platform reaffirmed its 2016 EBITDA guidance. The company also announced it would hold an investor day in September, where it will provide an update on strategy and longer-term financial outlook.

From Bill Ackman (Trades, Portfolio)'s first quarter shareholder letter.

Check out Bill Ackman latest stock trades

Bill Ackman Comments on Platform Specialty Products - Jan 27, 2016

Our most glaring, albeit small, unforced error was buying additional stock in Platform Specialty Products (NYSE:PAH) at $25 per share to assist the company in financing an acquisition. We paid too much as we assumed the new transaction would create substantial value, and because we assigned too much platform value to the company. Our assessment was incorrect as execution difficulties, operating issues, currency effects, and financing issues have destroyed rather than created value.

From Bill Ackman (Trades, Portfolio)'s Pershing Square Annual Investor Letter 2015.

Check out Bill Ackman latest stock trades

Bill Ackman Comments on Platform Specialty Products - Dec 16, 2015

Platform Specialty Products (NYSE:PAH)

During the third quarter, PAH’s share price declined 51%. While there were several developments at the company which contributed to the decline in the share price, many companies that have been highly acquisitive or compete in the agricultural chemicals industry also experienced significant share price declines during the quarter. For example, highly acquisitive companies such as XPO Logistics, Altice, and Colfax each exhibited share price declines of between 35% and 47% during the quarter, and the share price of FMC, PAH’s closest agricultural peer, declined 35% during the same period.

During the last several months, PAH announced the resignation, hiring, and promotion of several key executive roles. In August, Wayne Hewett, former President and head of the agricultural solutions business, left the company. In October, Dan Leever, the CEO of PAH, resigned. Dan stated that his resignation occurred due to disagreements with Chairman Martin Franklin regarding management style and the cultural integration of acquired companies. PAH also recently hired a new CFO, Sanjiv Khattri, and promoted its former head of corporate development, Ben Gliklich, to COO. On an investor call in October, Martin reiterated his commitment to PAH and explained that his involvement with the company will be even greater than it has been in the past. Martin and other members of the board and management have made substantial stock purchases in recent weeks.

PAH has reduced its EBITDA guidance twice in 2015. In August, the company reduced 2015 EBITDA guidance by approximately 5% from its initial guidance in March. In October, PAH further reduced its 2015 EBITDA guidance by an additional 12%. The company has explained that the primary drivers of the guidance reductions are worsening foreign exchange rates and a change in distribution strategy in the agricultural solutions business to realign inventory levels to more closely match underlying demand.

During the quarter, the company provided additional details regarding the financing for its pending acquisition of Alent. In October, PAH reiterated that it had obtained an underwritten commitment for long-term debt financing at what it believes to be competitive market rates for the $1.8 billion cash portion of the purchase price. In addition, the company clarified that it does not need to issue additional equity to finance the closing of the Alent acquisition. On December 1st, Platform completed its acquisition of Alent.

While Platform is clearly a work in progress, we have a high degree of confidence in Martin Franklin and his team. Yesterday, Martin’s largest holding, Jarden Corp., where he has served as Executive Chair, agreed to be acquired by Newell Rubbermaid. Under Martin’s leadership, Jarden’s stock price has increased approximately 50 times. Martin will be stepping down as Executive Chair, but will remain on the board of the merged company. We view this sale as favorable for Platform and Nomad Foods as he will now be able to devote more of his time to these companies.

From Bill Ackman (Trades, Portfolio)'s Pershing Square Holdings third quarter 2015 letter to shareholders.

Check out Bill Ackman latest stock trades

Top Ranked Articles about Platform Specialty Products Corp

Bill Ackman Comments on Platform Guru stock highlight
Platform (NYSE:PAH)’s earnings continued to grow this quarter as growth in the Performance Solutions business offset a decline in the Ag Solutions business. Platform’s organic revenue declined 1%, as Performance Solutions grew 4% and Ag Solutions declined 5%. The growth in the Performance Solutions segment continued to be driven by the positive results of the electronics business it recently acquired from Alent and strength in its industrial business. The decline in Ag Solutions resulted primarily from the ongoing drought in Brazil, which has caused buyers to delay their typical purchases in advance of the planting season. If the drought abates within the next few months, management believes it is likely it will recover these sales in future quarters.

Platform’s organic EBITDA increased 1%. Performance Solutions organic EBITDA grew 4% due to revenue growth and ongoing cost synergies from the acquisition of Alent, which was somewhat offset by a higher mix of sales from lower margin products. Ag Solutions organic EBITDA declined 3%, as the portion of sales from higher-margin products increased and the Read more...
Platform Specialty Products Corporation Announces Pricing of Senior Notes Offering
Platform Specialty Products Corporation Announces Launch of Senior Notes Offering
Platform Specialty Products Corporation Commences Cash Tender Offer and Consent Solicitation for Any and All of its Outstanding 10.375% Senior Notes due 2021
Platform Specialty Products Corporation Announces Date for Release of 2017 Third Quarter Financial Results
Platform Specialty Products Corporation Completes Repricing of $1.4 Billion of Term Loans
Platform Specialty Products Corporation to Present at Credit Suisse 30th Annual Basic Materials Conference
Platform Specialty Products Corporation Announces Intention to Separate into Two Public Companies
Bill Ackman Comments on Platform Specialty Products Corp Guru stock highlight
Platform (NYSE:PAH) reported strong earnings this quarter due to continued organic revenue growth and positive results from its ongoing cost savings initiatives. Platform’s organic revenue increased 2%, as Performance Solutions grew 6% and Ag Solutions declined 2%. The growth in the Performance Solutions segment was due primarily to the positive results of the electronics business it recently acquired from Alent and strength in its industrial business. The modest decline in Ag Solutions resulted from poor weather conditions in Eastern Europe and the restructuring of its business in Africa. Ag Solutions reported positive growth in all of its key regions outside of Eastern Europe and Africa. Read more...
Platform Specialty Products Corporation Announces Date for Release of 2017 Second Quarter Financial Results

Ratios

vs
industry
vs
history
Forward PE Ratio 9.80
PAH's Forward PE Ratio is ranked lower than
76% of the 96 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 17.30 vs. PAH: 9.80 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
Price-to-Owner-Earnings 203.25
PAH's Price-to-Owner-Earnings is ranked higher than
55% of the 512 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 24.00 vs. PAH: 203.25 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
PAH' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 0  Med: 0 Max: 204.27
Current: 203.25
0
204.27
PB Ratio 1.07
PAH's PB Ratio is ranked higher than
78% of the 1099 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 2.00 vs. PAH: 1.07 )
Ranked among companies with meaningful PB Ratio only.
PAH' s PB Ratio Range Over the Past 10 Years
Min: 0.77  Med: 1.01 Max: 1.14
Current: 1.07
0.77
1.14
PS Ratio 0.86
PAH's PS Ratio is ranked higher than
70% of the 1095 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.38 vs. PAH: 0.86 )
Ranked among companies with meaningful PS Ratio only.
PAH' s PS Ratio Range Over the Past 10 Years
Min: 0.72  Med: 1.09 Max: 6.1
Current: 0.86
0.72
6.1
Price-to-Free-Cash-Flow 13.42
PAH's Price-to-Free-Cash-Flow is ranked higher than
70% of the 359 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 19.81 vs. PAH: 13.42 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
PAH' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 7.71  Med: 18.81 Max: 58.76
Current: 13.42
7.71
58.76
Price-to-Operating-Cash-Flow 10.44
PAH's Price-to-Operating-Cash-Flow is ranked higher than
56% of the 469 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 11.23 vs. PAH: 10.44 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
PAH' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 6.53  Med: 15.64 Max: 53.1
Current: 10.44
6.53
53.1
EV-to-EBIT 21.88
PAH's EV-to-EBIT is ranked lower than
62% of the 969 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 15.64 vs. PAH: 21.88 )
Ranked among companies with meaningful EV-to-EBIT only.
PAH' s EV-to-EBIT Range Over the Past 10 Years
Min: 21.42  Med: 93.7 Max: 706.2
Current: 21.88
21.42
706.2
EV-to-EBITDA 10.05
PAH's EV-to-EBITDA is ranked higher than
61% of the 994 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 12.33 vs. PAH: 10.05 )
Ranked among companies with meaningful EV-to-EBITDA only.
PAH' s EV-to-EBITDA Range Over the Past 10 Years
Min: 9.84  Med: 46.1 Max: 706.2
Current: 10.05
9.84
706.2
EV-to-Revenue 1.79
PAH's EV-to-Revenue is ranked lower than
56% of the 1104 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.54 vs. PAH: 1.79 )
Ranked among companies with meaningful EV-to-Revenue only.
PAH' s EV-to-Revenue Range Over the Past 10 Years
Min: 2.2  Med: 2.9 Max: 4.6
Current: 1.79
2.2
4.6
Current Ratio 2.05
PAH's Current Ratio is ranked higher than
52% of the 1015 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.90 vs. PAH: 2.05 )
Ranked among companies with meaningful Current Ratio only.
PAH' s Current Ratio Range Over the Past 10 Years
Min: 1.66  Med: 2.11 Max: 7.71
Current: 2.05
1.66
7.71
Quick Ratio 1.55
PAH's Quick Ratio is ranked higher than
55% of the 1015 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.38 vs. PAH: 1.55 )
Ranked among companies with meaningful Quick Ratio only.
PAH' s Quick Ratio Range Over the Past 10 Years
Min: 1.3  Med: 1.65 Max: 7.02
Current: 1.55
1.3
7.02
Days Inventory 89.55
PAH's Days Inventory is ranked lower than
71% of the 1075 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 66.54 vs. PAH: 89.55 )
Ranked among companies with meaningful Days Inventory only.
PAH' s Days Inventory Range Over the Past 10 Years
Min: 36.92  Med: 80.2 Max: 120.72
Current: 89.55
36.92
120.72
Days Sales Outstanding 113.17
PAH's Days Sales Outstanding is ranked lower than
87% of the 922 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 62.94 vs. PAH: 113.17 )
Ranked among companies with meaningful Days Sales Outstanding only.
PAH' s Days Sales Outstanding Range Over the Past 10 Years
Min: 69.37  Med: 124.53 Max: 146.87
Current: 113.17
69.37
146.87
Days Payable 73.87
PAH's Days Payable is ranked higher than
72% of the 878 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 49.88 vs. PAH: 73.87 )
Ranked among companies with meaningful Days Payable only.
PAH' s Days Payable Range Over the Past 10 Years
Min: 51.84  Med: 77.29 Max: 106.01
Current: 73.87
51.84
106.01

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -39.10
PAH's 3-Year Average Share Buyback Ratio is ranked lower than
92% of the 592 Companies
in the Global Specialty Chemicals industry.

( Industry Median: -2.60 vs. PAH: -39.10 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
PAH' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -39.1  Med: 0 Max: 0
Current: -39.1
-39.1
0

Valuation & Return

vs
industry
vs
history
Price-to-Median-PS-Value 0.77
PAH's Price-to-Median-PS-Value is ranked lower than
99.99% of the 1005 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.29 vs. PAH: 0.77 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
PAH' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0  Med: 0.93 Max: 5.59
Current: 0.77
0
5.59
Earnings Yield (Greenblatt) % 4.58
PAH's Earnings Yield (Greenblatt) % is ranked lower than
53% of the 1141 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 5.02 vs. PAH: 4.58 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
PAH' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 0.1  Med: 1.1 Max: 4.67
Current: 4.58
0.1
4.67

More Statistics

Revenue (TTM) (Mil) $3,657.20
EPS (TTM) $ -0.54
Beta2.64
Short Percentage of Float7.25%
52-Week Range $8.40 - 14.82
Shares Outstanding (Mil)287.10

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 3,682 3,832 3,970
EPS ($) 0.72 1.02 1.35
EPS without NRI ($) 0.72 1.02 1.35
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($)

Piotroski F-Score Details

Piotroski F-Score: 66
Positive ROAN
Positive CFROAY
Higher ROA yoyY
CFROA > ROAY
Lower Leverage yoyY
Higher Current Ratio yoyY
Less Shares Outstanding yoyN
Higher Gross Margin yoyY
Higher Asset Turnover yoyN

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}